BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

What symbol and exchange does Beyondspring - shares trade?

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

What is Beyondspring - stock price doing today?

As of December 17, 2025, BYSI stock price declined to $1.90 with 89,999 million shares trading.

What is Beyondspring -'s Beta?

BYSI has a beta of -0.16, meaning it tends to be less sensitive to market movements. BYSI has a correlation of 0.00 to the broad based SPY ETF.

How much is Beyondspring - worth?

BYSI has a market cap of $78.13 million. This is considered a Micro Cap stock.

What is the highest and lowest price Beyondspring - traded in the last 3 year period?

In the last 3 years, BYSI traded as high as $4.00 and as low as $.65.

What are the top ETFs holding Beyondspring -?

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): VXF, VTI, IWC.

Is Beyondspring - (BYSI) a good investment?

BYSI has outperformed the market in the last year with a price return of +16.6% while the SPY ETF gained +12.3%. BYSI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +6.1% and 0.0%, respectively, while the SPY returned +2.1% and -1.8%, respectively.

What are the support and resistance levels for Beyondspring - (BYSI)?

BYSI support price is $1.82 and resistance is $2.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.